Form 8-K - Current report:
SEC Accession No. 0001193125-19-133882
Filing Date
2019-05-02
Accepted
2019-05-02 08:01:56
Documents
2
Period of Report
2019-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d740978d8k.htm 8-K 17344
2 EX-99.1 d740978dex991.htm EX-99.1 56701
  Complete submission text file 0001193125-19-133882.txt   75235
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 19789796
SIC: 2834 Pharmaceutical Preparations